HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[Randomized trial of elliptinium acetate and tamoxifen in the treatment of inoperable hepatocellular carcinoma].

AuthorsH Jouanolle, D Delamaire, Y Deugnier, D Lhéry, M Simon, P Brissot, M Bourel
JournalGastroentérologie clinique et biologique (Gastroenterol Clin Biol) Vol. 10 Issue 2 Pg. 185-7 (Feb 1986) ISSN: 0399-8320 [Print] FRANCE
Vernacular TitleEssai randomisé de l'acétate d'elliptinium et du tamoxifène dans le traitement des carcinomes hépatocellulaires inopérables.
PMID3009255 (Publication Type: Clinical Trial, Letter, Randomized Controlled Trial)
Chemical References
  • Alkaloids
  • Ellipticines
  • Tamoxifen
  • elliptinium
Topics
  • Adult
  • Aged
  • Alkaloids (therapeutic use)
  • Carcinoma, Hepatocellular (drug therapy)
  • Drug Evaluation
  • Ellipticines (therapeutic use)
  • Female
  • Humans
  • Liver Neoplasms (drug therapy)
  • Male
  • Middle Aged
  • Random Allocation
  • Tamoxifen (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: